| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kyle Volpe, Rachel S Wightma. Delta-What? Deciphering the World of Cannabinoids. Rhode Island medical journal (2013). vol 105. issue 7. 2022-08-30. PMID:36041020. |
recent years have seen a rise in popularity of these alternative cannabinoids, and this trend is likely to continue with the continuing legalization of recreational cannabis throughout the united states. |
2022-08-30 |
2023-08-14 |
Not clear |
| Melanie Camcejo, Emily Hillman, Heather Iso. Cannabinoid Hyperemesis Syndrome: Lighting Up an Emergency Department Near You. Missouri medicine. vol 119. issue 3. 2022-08-29. PMID:36035580. |
cannabis legalization may increase the rates of emergency department presentations and hospitalizations from cannabinoid hyperemesis syndrome (chs). |
2022-08-29 |
2023-08-14 |
Not clear |
| Victoria R Zeger, David S Bell, Jason S Herrington, Jared L Anderso. Selective isolation of pesticides and cannabinoids using polymeric ionic liquid-based sorbent coatings in solid-phase microextraction coupled to high-performance liquid chromatography. Journal of chromatography. A. vol 1680. 2022-08-28. PMID:36030566. |
the high abundance of cannabinoids within cannabis samples presents an issue for pesticide testing as cannabinoids are often co-extracted with pesticides using various sample preparation techniques. |
2022-08-28 |
2023-08-14 |
Not clear |
| Victoria R Zeger, David S Bell, Jason S Herrington, Jared L Anderso. Selective isolation of pesticides and cannabinoids using polymeric ionic liquid-based sorbent coatings in solid-phase microextraction coupled to high-performance liquid chromatography. Journal of chromatography. A. vol 1680. 2022-08-28. PMID:36030566. |
the selectivity of four pil sorbent coatings towards 20 pesticides and six cannabinoids, including cannabidiol and Δ |
2022-08-28 |
2023-08-14 |
Not clear |
| Rosario Licitra, Maria Marchese, Valentina Naef, Asahi Ogi, Marco Martinelli, Claudia Kiferle, Baldassare Fronte, Filippo Maria Santorell. A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment. Biomedicines. vol 10. issue 8. 2022-08-26. PMID:36009367. |
although the bulk of research on cannabis and cannabinoids is based on in vitro or rodent models, the zebrafish has now emerged as a powerful in vivo model for drug-screening studies and translational research. |
2022-08-26 |
2023-08-14 |
zebrafish |
| Michał Graczyk, Agata Anna Lewandowska, Piotr Melnyczok, Adam Zgliński, Małgorzata Łukowic. Cannabinoids-Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series. Biomedicines. vol 10. issue 8. 2022-08-26. PMID:36009411. |
the clinical effects of cannabinoids depend, among other things, on the activity of the endocannabinoid system, the proportion of phytocannabinoids, such as Δ9-tetrahydrocannabinol (thc) and cannabidiol (cbd), and the dosage used. |
2022-08-26 |
2023-08-14 |
Not clear |
| Dillon Nussbaum, Sapana Desai, Adrianna Gonzalez-Lopez, Jason E Hawkes, George Gondo, Adam Friedma. Practices and perspectives on medical cannabis and cannabinoids: A survey of the National Psoriasis Foundation Medical Advisory Board. JAAD international. vol 9. 2022-08-26. PMID:36017106. |
practices and perspectives on medical cannabis and cannabinoids: a survey of the national psoriasis foundation medical advisory board. |
2022-08-26 |
2023-08-14 |
Not clear |
| Carlos Henrique Alves Jesus, Matheus Vinicius Ferreira, Aléxia Thamara Gasparin, Evelize Stacoviaki Rosa, Karina Genaro, José Alexandre de Souza Crippa, Juliana Geremias Chichorro, Joice Maria da Cunh. Cannabidiol enhances the antinociceptive effects of morphine and attenuates opioid-induced tolerance in the chronic constriction injury model. Behavioural brain research. 2022-08-26. PMID:36028000. |
cannabidiol (cbd) has shown potential in the treatment of np and the combination between opioids and cannabinoids has provided promising results on pain relief. |
2022-08-26 |
2023-08-14 |
rat |
| Verónica Baron-Flores, Araceli Diaz-Ruiz, Jorge Manzanares, Camilo Rios, Masha Burelo, Gustavo Jardon-Guadarrama, María de Los Ángeles Martínez-Cárdenas, Alfonso Mata-Bermude. Cannabidiol attenuates hypersensitivity and oxidative stress after traumatic spinal cord injury in rats. Neuroscience letters. 2022-08-26. PMID:36028005. |
cannabidiol (cbd) is one of the two most crucial cannabinoid components of the cannabis plant and has been proposed as a potential treatment for np. |
2022-08-26 |
2023-08-14 |
rat |
| Pabitra Chandra Das, Alec Roger Vista, Lope G Tabil, Oon-Doo Bai. Postharvest Operations of Cannabis and Their Effect on Cannabinoid Content: A Review. Bioengineering (Basel, Switzerland). vol 9. issue 8. 2022-08-25. PMID:36004888. |
postharvest operations of cannabis and their effect on cannabinoid content: a review. |
2022-08-25 |
2023-08-14 |
Not clear |
| Nicholas Frane, Erik Stapleton, Cesar Iturriaga, Maximillian Ganz, Vijay Rasquinha, Robert Duart. Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study. Journal of cannabis research. vol 4. issue 1. 2022-08-23. PMID:35999581. |
cannabidiol (cbd) is a non-psychoactive cannabinoid that has shown promise in preclinical studies to reduce inflammation and pain associated with arthritis. |
2022-08-23 |
2023-08-14 |
human |
| María Alías-Ferri, Manuela Pellegrini, Emilia Marchei, Roberta Pacifici, Maria Concetta Rotolo, Simona Pichini, Clara Pérez-Mañá, Esther Papaseit, Robert Muga, Francina Fonseca, Magi Farré, Marta Torren. Synthetic cannabinoids use in a sample of opioid-use disorder patients. Frontiers in psychiatry. vol 13. 2022-08-22. PMID:35990071. |
cannabis is the most widely consumed illegal drug in the world and synthetic cannabinoids are increasingly gaining popularity and replacing traditional cannabis. |
2022-08-22 |
2023-08-14 |
Not clear |
| María Alías-Ferri, Manuela Pellegrini, Emilia Marchei, Roberta Pacifici, Maria Concetta Rotolo, Simona Pichini, Clara Pérez-Mañá, Esther Papaseit, Robert Muga, Francina Fonseca, Magi Farré, Marta Torren. Synthetic cannabinoids use in a sample of opioid-use disorder patients. Frontiers in psychiatry. vol 13. 2022-08-22. PMID:35990071. |
since, people with opioids use disorder use widely cannabis, they are a population vulnerable to use synthetic cannabinoids. |
2022-08-22 |
2023-08-14 |
Not clear |
| María Alías-Ferri, Manuela Pellegrini, Emilia Marchei, Roberta Pacifici, Maria Concetta Rotolo, Simona Pichini, Clara Pérez-Mañá, Esther Papaseit, Robert Muga, Francina Fonseca, Magi Farré, Marta Torren. Synthetic cannabinoids use in a sample of opioid-use disorder patients. Frontiers in psychiatry. vol 13. 2022-08-22. PMID:35990071. |
several different synthetic cannabinoids were detected and a non-negligible percentage of natural cannabis was detected among our sample. |
2022-08-22 |
2023-08-14 |
Not clear |
| Tomohiro Tokutake, Takashi Asano, Hajime Miyanishi, Shigetoshi Nakaya, Naotaka Izuo, Atsumi Nitt. Cannabinoid Type 1 Receptors in the Basolateral Amygdala Regulate ACPA-Induced Place Preference and Anxiolytic-Like Behaviors. Neurochemical research. 2022-08-19. PMID:35984590. |
Δ9-tetrahydrocannabinol (thc), the main active substance in cannabis, binds and affects cannabinoid type 1 receptors (cb1r) in the brain. |
2022-08-19 |
2023-08-14 |
mouse |
| Pamela R Hughes, Jennifer Nwokoch. Medical Cannabis or Cannabinoids for Chronic Pain: BMJ Rapid Recommendation. American family physician. vol 106. issue 2. 2022-08-17. PMID:35977118. |
medical cannabis or cannabinoids for chronic pain: bmj rapid recommendation. |
2022-08-17 |
2023-08-14 |
Not clear |
| Hock Chuan Yeo, Vaishnavi Amarr Reddy, Bong-Gyu Mun, Sing Hui Leong, Savitha Dhandapani, Sarojam Rajani, In-Cheol Jan. Comparative Transcriptome Analysis Reveals Coordinated Transcriptional Regulation of Central and Secondary Metabolism in the Trichomes of Cannabis Cultivars. International journal of molecular sciences. vol 23. issue 15. 2022-08-12. PMID:35955443. |
cannabis is one of the few plant genera capable of producing cannabinoids, the effects of which are synergized by terpene interactions. |
2022-08-12 |
2023-08-14 |
Not clear |
| Tracy A Klein, Julia A Dilley, Janessa M Graves, Erica L Liebel. Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016-2019. Clinical toxicology (Philadelphia, Pa.). 2022-08-09. PMID:35942512. |
synthetic cannabinoid poisonings and access to the legal cannabis market: findings from us national poison centre data 2016-2019. |
2022-08-09 |
2023-08-14 |
Not clear |
| Tracy A Klein, Julia A Dilley, Janessa M Graves, Erica L Liebel. Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016-2019. Clinical toxicology (Philadelphia, Pa.). 2022-08-09. PMID:35942512. |
to investigate trends in synthetic cannabinoid exposures reported to united states (us) poison control centres, and their association with status of state cannabis legalisation. |
2022-08-09 |
2023-08-14 |
Not clear |
| Tongxin Wang, Alex Zakharov, Beatriz Gomez, Alex Lyubimov, Nathalie L Trottier, Wayne S Schwark, Joseph J Wakshla. Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste. Frontiers in veterinary science. vol 9. 2022-08-08. PMID:35937287. |
cat owners are also using hemp-based products for arthritis, anxiety and neoplastic disorders with no studies assessing hemp cannabinoids, namely cannabidiol efficacy, for such disorders. |
2022-08-08 |
2023-08-14 |
cat |